Wang, L., Xu, L., Han, S., & Zhu, X. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway. Wiley.
Chicago Style (17th ed.) CitationWang, Lile, Lu Xu, Shuhua Han, and Xiaoli Zhu. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway. Wiley.
MLA (9th ed.) CitationWang, Lile, et al. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway. Wiley.
Warning: These citations may not always be 100% accurate.